MedPacto (Korea) Top Management
235980 Stock | KRW 4,425 135.00 2.96% |
MedPacto employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of MedPacto's management performance can provide insight into the company performance.
Ilho Ha Insider Chief Officer |
SeongJin Kim Insider Founder Officer |
MedPacto |
MedPacto Management Team Effectiveness
The company has return on total asset (ROA) of (0.2497) % which means that it has lost $0.2497 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (58.5384) %, meaning that it generated substantial loss on money invested by shareholders. MedPacto's management efficiency ratios could be used to measure how well MedPacto manages its routine affairs as well as how well it operates its assets and liabilities.MedPacto Workforce Comparison
MedPacto is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 522. MedPacto adds roughly 2.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
MedPacto Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. MedPacto Price Series Summation is a cross summation of MedPacto price series and its benchmark/peer.
MedPacto Notable Stakeholders
A MedPacto stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MedPacto often face trade-offs trying to please all of them. MedPacto's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MedPacto's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ilho Ha | Chief Officer | Profile | |
SeongJin Kim | Founder Officer | Profile |
About MedPacto Management Performance
The success or failure of an entity such as MedPacto often depends on how effective the management is. MedPacto management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MedPacto management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MedPacto management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers MS-1601A that targets TRG1 for cancers and autoimmune diseases and vactosertib for solid tumors. MedPacto is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of MedPacto's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MedPacto's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MedPacto's management manipulating its earnings.
MedPacto Workforce Analysis
Traditionally, organizations such as MedPacto use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MedPacto within its industry.MedPacto Manpower Efficiency
Return on MedPacto Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 8.5B | |
Net Loss Per Executive | 8.5B |
Complementary Tools for MedPacto Stock analysis
When running MedPacto's price analysis, check to measure MedPacto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedPacto is operating at the current time. Most of MedPacto's value examination focuses on studying past and present price action to predict the probability of MedPacto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedPacto's price. Additionally, you may evaluate how the addition of MedPacto to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |